Cargando…
Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of fibrosis. Liver biopsy remains the gold standard for the confirmation of fibrosis in NAFLD patients. Effective and non-invasive diagnosis of advanced fibrosis is essential to disease surveillance and treatment decisions. Herein w...
Autores principales: | Sang, Chao, Yan, Hongmei, Chan, Wah Kheong, Zhu, Xiaopeng, Sun, Tao, Chang, Xinxia, Xia, Mingfeng, Sun, Xiaoyang, Hu, Xiqi, Gao, Xin, Jia, Wei, Bian, Hua, Chen, Tianlu, Xie, Guoxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940822/ https://www.ncbi.nlm.nih.gov/pubmed/33708783 http://dx.doi.org/10.3389/fmed.2021.637652 |
Ejemplares similares
-
Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation
por: Zhu, Xiaopeng, et al.
Publicado: (2020) -
A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease
por: Yang, Xinyu, et al.
Publicado: (2022) -
Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
por: Yang, Xinyu, et al.
Publicado: (2021) -
Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression
por: Zhu, Xiaopeng, et al.
Publicado: (2018) -
FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c
por: Wang, Liu, et al.
Publicado: (2019)